$2,390.00

Hep3B/Cre stable cell line

Catalog number
CL-1882
Description
Hep3B/Cre cells are derived from the human Hep3B Hepatocellular carcinoma cell line by stably integration of a constitutive Cre recombinase stably expression construct. The Hep3B cell line has been widely used in cancer research, particularly in studies related to liver cancer, and drug screening. Hep3B/Cre cells stably express a nuclear localized Cre recombinase.

Product Details

Package Size 2 x 10^6 cells
Parental cell line Hep3B cells
Transgenic gene Cre recombinase
Mammalian selection Puromycin
Biosafety level 2
Storage Liquid nitrogen
Availability 3-4 weeks
Shipping condition dry ice
Copyright © 2024, FenicsBIO. All rights reserved.